These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 22348271)

  • 21. Thrombus-specific theranostic nanocomposite for codelivery of thrombolytic drug, algae-derived anticoagulant and NIR fluorescent contrast agent.
    Chang LH; Chuang EY; Cheng TM; Lin C; Shih CM; Wu AT; Jheng PR; Lu HY; Shih CC; Mi FL
    Acta Biomater; 2021 Oct; 134():686-701. PubMed ID: 34358695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A targeted ferritin-microplasmin based thrombolytic nanocage selectively dissolves blood clots.
    Seo J; Al-Hilal TA; Jee JG; Kim YL; Kim HJ; Lee BH; Kim S; Kim IS
    Nanomedicine; 2018 Apr; 14(3):633-642. PubMed ID: 29309907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new drug delivery system for intravenous coronary thrombolysis with thrombus targeting and stealth activity recoverable by ultrasound.
    Kawata H; Uesugi Y; Soeda T; Takemoto Y; Sung JH; Umaki K; Kato K; Ogiwara K; Nogami K; Ishigami K; Horii M; Uemura S; Shima M; Tabata Y; Saito Y
    J Am Coll Cardiol; 2012 Dec; 60(24):2550-7. PubMed ID: 23158532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombus-targeted nanocarrier attenuates bleeding complications associated with conventional thrombolytic therapy.
    Absar S; Nahar K; Kwon YM; Ahsan F
    Pharm Res; 2013 Jun; 30(6):1663-76. PubMed ID: 23468049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ADAMTS13 exerts a thrombolytic effect in microcirculation.
    Crescente M; Thomas GM; Demers M; Voorhees JR; Wong SL; Ho-Tin-Noé B; Wagner DD
    Thromb Haemost; 2012 Sep; 108(3):527-32. PubMed ID: 22782575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engineering of plasminogen activators for targeting to thrombus and heightening thrombolytic efficacy.
    Absar S; Gupta N; Nahar K; Ahsan F
    J Thromb Haemost; 2015 Sep; 13(9):1545-56. PubMed ID: 26074048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of intravenous bolus injection or continuous infusion of recombinant single chain urokinase-type plasminogen activator (saruplase) for thrombolysis. A canine model of combined coronary arterial and femoral venous thrombosis.
    Rapold HJ; Wu ZM; Stassen T; Van de Werf F; Collen D
    Blood; 1990 Oct; 76(8):1558-63. PubMed ID: 2119830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular imaging of fibrin deposition in deep vein thrombosis using fibrin-targeted near-infrared fluorescence.
    Hara T; Bhayana B; Thompson B; Kessinger CW; Khatri A; McCarthy JR; Weissleder R; Lin CP; Tearney GJ; Jaffer FA
    JACC Cardiovasc Imaging; 2012 Jun; 5(6):607-15. PubMed ID: 22698530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombolytic and Antiplatelet Effects of a Novel Plasminogen Activator from the Venom of Gloydius Brevicaudus Viper.
    Zhang Z; Lin L; Zhang J; Zhang Q; Zhao N; Wu L; Chen J; Wu Z; Wu G; Lin J; Chen Y; Xu Y
    J Atheroscler Thromb; 2015; 22(10):1080-90. PubMed ID: 26004931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microfluidic Modeling of Thrombolysis.
    Loyau S; Ho-Tin-Noé B; Bourrienne MC; Boulaftali Y; Jandrot-Perrus M
    Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2626-2637. PubMed ID: 30354249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An activated-platelet-sensitive nanocarrier enables targeted delivery of tissue plasminogen activator for effective thrombolytic therapy.
    Huang Y; Yu L; Ren J; Gu B; Longstaff C; Hughes AD; Thom SA; Xu XY; Chen R
    J Control Release; 2019 Apr; 300():1-12. PubMed ID: 30807804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Remaining perspectives of mutant and chimeric plasminogen activators.
    Lijnen HR; Collen D
    Ann N Y Acad Sci; 1992 Dec; 667():357-64. PubMed ID: 1309056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular imaging of factor XIIIa activity in thrombosis using a novel, near-infrared fluorescent contrast agent that covalently links to thrombi.
    Jaffer FA; Tung CH; Wykrzykowska JJ; Ho NH; Houng AK; Reed GL; Weissleder R
    Circulation; 2004 Jul; 110(2):170-6. PubMed ID: 15210587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombolytic therapy.
    Goldhaber SZ
    Adv Intern Med; 1999; 44():311-25. PubMed ID: 9929714
    [No Abstract]   [Full Text] [Related]  

  • 35. Engineered Nanoplatelets for Targeted Delivery of Plasminogen Activators to Reverse Thrombus in Multiple Mouse Thrombosis Models.
    Xu J; Zhang Y; Xu J; Liu G; Di C; Zhao X; Li X; Li Y; Pang N; Yang C; Li Y; Li B; Lu Z; Wang M; Dai K; Yan R; Li S; Nie G
    Adv Mater; 2020 Jan; 32(4):e1905145. PubMed ID: 31788896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet microparticle-inspired clot-responsive nanomedicine for targeted fibrinolysis.
    Pawlowski CL; Li W; Sun M; Ravichandran K; Hickman D; Kos C; Kaur G; Sen Gupta A
    Biomaterials; 2017 Jun; 128():94-108. PubMed ID: 28314136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation and characterization of anionic oligopeptide-modified tissue plasminogen activator for triggered delivery: an approach for localized thrombolysis.
    Absar S; Choi S; Ahsan F; Cobos E; Yang VC; Kwon YM
    Thromb Res; 2013 Mar; 131(3):e91-9. PubMed ID: 23269380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration.
    Collen D; Stassen JM; Verstraete M
    J Clin Invest; 1983 Feb; 71(2):368-76. PubMed ID: 6681615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo thrombolysis with targeted microbubbles loading tissue plasminogen activator in a rabbit femoral artery thrombus model.
    Hua X; Zhou L; Liu P; He Y; Tan K; Chen Q; Gao Y; Gao Y
    J Thromb Thrombolysis; 2014 Jul; 38(1):57-64. PubMed ID: 24671732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factor XIII Prevents Pulmonary Emboli in Mice by Stabilizing Deep Vein Thrombi.
    Shaya SA; Gani DM; Weitz JI; Kim PY; Gross PL
    Thromb Haemost; 2019 Jun; 119(6):992-999. PubMed ID: 31005064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.